Erratum to: Diagnostic performance of Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients.
作者信息
Afshar-Oromieh Ali, Holland-Letz Tim, Giesel Frederik L, Kratochwil Clemens, Mier Walter, Haufe Sabine, Debus Nils, Eder Matthias, Eisenhut Michael, Schäfer Martin, Neels Oliver, Hohenfellner Markus, Kopka Klaus, Kauczor Hans-Ulrich, Debus Jürgen, Haberkorn Uwe
机构信息
Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany.
Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Centre, Heidelberg, Germany.
出版信息
Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1781. doi: 10.1007/s00259-017-3763-8.
Abstract
摘要
相似文献
1
Erratum to: Diagnostic performance of Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients.《镓标记的PSMA-11（HBED-CC）PET/CT对复发性前列腺癌患者的诊断性能：1007例患者的评估》勘误
Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1781. doi: 10.1007/s00259-017-3763-8.
2
Integrated Ga-HBED-CC-PSMA-PET/MRI in patients with suspected recurrent prostate cancer.整合镓-六氮杂环十二烷四羧酸-环糊精-前列腺特异性膜抗原正电子发射断层扫描/磁共振成像在疑似复发性前列腺癌患者中的应用
Nuklearmedizin. 2017 Jun 13;56(3):73-81. doi: 10.3413/Nukmed-0850-16-09. Epub 2017 Apr 12.
3
Simultaneous Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer.镓-PSMA HBED-CC PET/MRI 联合检查可提高前列腺癌原发灶的定位诊断。
Eur Urol. 2016 Nov;70(5):829-836. doi: 10.1016/j.eururo.2015.12.053. Epub 2016 Jan 18.
4
Extent of disease in recurrent prostate cancer determined by [(68)Ga]PSMA-HBED-CC PET/CT in relation to PSA levels, PSA doubling time and Gleason score.通过[（68）Ga]PSMA-HBED-CC PET/CT测定的复发性前列腺癌疾病范围与PSA水平、PSA倍增时间和 Gleason评分的关系
Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):397-403. doi: 10.1007/s00259-015-3240-1. Epub 2015 Nov 12.
5
Intrapatient Comparison of 111In-PSMA I&T SPECT/CT and Hybrid 68Ga-HBED-CC PSMA PET in Patients With Early Recurrent Prostate Cancer.患者内比较 111In-PSMA I&T SPECT/CT 和 68Ga-HBED-CC PSMA PET 混合显像在早期复发性前列腺癌患者中的应用。
Clin Nucl Med. 2016 Sep;41(9):e397-402. doi: 10.1097/RLU.0000000000001273.
6
(68)Ga-HBED-CC-PSMA PET/CT Versus Histopathology in Primary Localized Prostate Cancer: A Voxel-Wise Comparison.（68）镓-六氮杂环十二烷四乙酸-环糊精-前列腺特异性膜抗原正电子发射断层显像/计算机断层扫描与原发性局限性前列腺癌组织病理学的体素级比较
Theranostics. 2016 Jun 18;6(10):1619-28. doi: 10.7150/thno.15344. eCollection 2016.
7
Preliminary results on response assessment using Ga-HBED-CC-PSMA PET/CT in patients with metastatic prostate cancer undergoing docetaxel chemotherapy.使用 Ga-HBED-CC-PSMA PET/CT 评估转移性前列腺癌患者接受多西他赛化疗后反应的初步结果。
Eur J Nucl Med Mol Imaging. 2018 Apr;45(4):602-612. doi: 10.1007/s00259-017-3887-x. Epub 2017 Nov 28.
8
Comparison of Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology.基于与组织病理学逐片比较，比较镓-羟基苄基乙二胺-N,N'-二乙酸-环糊精前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描（Ga-HBED-CC PSMA-PET/CT）和多参数磁共振成像（MRI）在原发性前列腺癌患者中检测大体肿瘤体积的情况。
Theranostics. 2017 Jan 1;7(1):228-237. doi: 10.7150/thno.16638. eCollection 2017.
9
Biodistribution and radiation dosimetry of (68)Ga-PSMA HBED CC-a PSMA specific probe for PET imaging of prostate cancer.（68）镓标记的前列腺特异性膜抗原（PSMA）-六氮杂环十二烷四乙酸（HBED-CC）——一种用于前列腺癌PET成像的PSMA特异性探针的生物分布及辐射剂量测定
Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):1962-70. doi: 10.1007/s00259-016-3424-3. Epub 2016 May 20.
10
Could 68-Ga PSMA PET/CT become a new tool in the decision-making strategy of prostate cancer patients with biochemical recurrence of PSA after radical prostatectomy? A preliminary, monocentric series.68Ga PSMA PET/CT 能否成为根治性前列腺切除术后 PSA 生化复发的前列腺癌患者决策策略中的新工具？一项初步的单中心研究。
Radiol Med. 2018 Sep;123(9):719-725. doi: 10.1007/s11547-018-0890-7. Epub 2018 Apr 23.
引用本文的文献
1
Assessment of 18F-DCFPyL PSMA PET/CT and PET/MR quantitative parameters for reference standard organs: Inter-reader, inter-modality, and inter-patient variability.18F-DCFPyL PSMA PET/CT 和 PET/MR 定量参数评估参考标准器官：读者间、模态间和患者间可变性。
PLoS One. 2023 Apr 6;18(4):e0283830. doi: 10.1371/journal.pone.0283830. eCollection 2023.
2
Can SUVmax values of Ga-68-PSMA PET/CT scan predict the clinically significant prostate cancer?Ga-68-PSMA PET/CT扫描的SUVmax值能否预测具有临床意义的前列腺癌？
Nucl Med Commun. 2019 Jan;40(1):86-91. doi: 10.1097/MNM.0000000000000942.
3
Ga-PSMA and C-Choline comparison using a tri-modality PET/CT-MRI (3.0 T) system with a dedicated shuttle.使用带有专用穿梭装置的三模态PET/CT-MRI（3.0 T）系统对镓-PSMA和碳-胆碱进行比较。
Eur J Hybrid Imaging. 2018;2(1):9. doi: 10.1186/s41824-018-0027-1. Epub 2018 May 7.
4
Could 68-Ga PSMA PET/CT become a new tool in the decision-making strategy of prostate cancer patients with biochemical recurrence of PSA after radical prostatectomy? A preliminary, monocentric series.68Ga PSMA PET/CT 能否成为根治性前列腺切除术后 PSA 生化复发的前列腺癌患者决策策略中的新工具？一项初步的单中心研究。
Radiol Med. 2018 Sep;123(9):719-725. doi: 10.1007/s11547-018-0890-7. Epub 2018 Apr 23.
Zotero 插件